8 withdrawn. 8 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Withdrawn 8 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Dermatitis, Atopic: new trials by email Literature Review of Dermatitis, Atopic trials Research Report on Dermatitis, Atopic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study of Cizutamig in IgE Mediated Diseases Cizutamig - IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy | Phase 1 | Withdrawn | Candid Therapeutics | 2026-04-01 | 2026-07-22 | |
| A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis BxC-I17e, Placebo - Atopic Dermatitis | Phase 1 | Withdrawn | Brexogen Inc. | 2024-05-01 | 2024-08-09 | |
| A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis BX005-A, Placebo - Atopic Dermatitis | Phase 1 / Phase 2 | Withdrawn | BiomX, Inc. | 2022-05-01 | 2025-08-03 | |
| Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival Pre-Treatment with Dial liquid antibacterial soap, Control - Atopic Dermatitis, Eczema | Phase 1 | Withdrawn | University of California, San Diego | 2016-06-01 | 2020-11-05 | |
| Probiotic Supplementation in Breastfed Newborn Infants B. infantis, Placebo - Atopic Dermatitis, Food Allergies | Phase 1 | Withdrawn | Emanual Maverakis, MD | 2015-10-01 | 2019-11-15 | |
| 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis Sodium Hypochlorite - Atopic Dermatitis | Phase 1 | Withdrawn | Makati Medical Center | 2014-07-01 | 2015-10-20 | |
| Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) MVA (smallpox vaccine) - Smallpox, Atopic Dermatitis | Phase 1 | Withdrawn | Sanofi Pasteur, a Sanofi Company | 2006-10-01 | 2014-01-22 | |
| CT 327 in the "Atopy Patch Test" Model CT327 application, Placebo, Active comparator - Atopic Dermatitis | Phase 1 | Withdrawn | Creabilis SA | 20 | 2011-06-07 |
Food Hypersensitivity (2) · Asthma (1) · Eczema (1) · Egg Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Milk Hypersensitivity (1) · Nut Hypersensitivity (1) · Peanut Hypersensitivity (1) · Rhinitis, Allergic (1) · Rhinosinusitis (1) · Smallpox (1) · Urticaria (1) · Wheat Hypersensitivity (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8) · Dermatitis (8) · Genetic Diseases, Inborn (8) · Hypersensitivity (8) · Immune System Diseases (8) · Skin Diseases (8) · Skin Diseases, Eczematous (8) · Skin Diseases, Genetic (8) · Skin and Connective Tissue Diseases (8) · Hypersensitivity, Immediate (7) · Infections (2) · Bronchial Diseases (1) · DNA Virus Infections (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1)
Probiotics (1) · Sodium Hypochlorite (1) · smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic (1)
BiomX, Inc. (1) · Brexogen Inc. (1) · Candid Therapeutics (1) · Creabilis SA (1) · Emanual Maverakis, MD (1) · Makati Medical Center (1) · Sanofi Pasteur, a Sanofi Company (1) · University of California, San Diego (1)
United States (3) · Australia (1) · Germany (1) · Philippines (1)
Donna Marie L. Sarrosa, MD, FPDS (1) · Emanual Maverakis, MD (1) · Jamaine Melisse L Cruz, MD (1) · Prof. Dr. Med. Johannes Ring (1) · Urania Rappo, MD (1)